Tokyo-Based Terumo Constructs New Production Facility Amid Strong Catheter Demand
This article was originally published in PharmAsia News
Tokyo-based Terumo Corp will construct a new catheter production facility in Fujinomiya, Shizuoka Prefecture. Terumo's catheter products are used for heart disease treatments, and its guide wire accounts for 30 percent of the worldwide market share. Terumo's blood vessel balloon catheters and stents are directly contributing to the company's global expansion. Less painful compared to surgery, demand for catheter treatment is estimated to be strong around the world. The new facility will start producing from Fall 2009 and will supply the U.S., European and Asian markets. (Click here for more - Japanese language
You may also be interested in...
The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.